Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey
Acta Diabetologica · 27.05.2024 · 61 (11) · 1403-1412
DOI: 10.1007/s00592-024-02301-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 27.05.2024. Verfasst von Wenjie Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Hauptthemen laut MEDLINE: Nutrition Surveys, Neoplasms, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: Inflammation plays a crucial role in the interconnection between diabetes and cancer. Our study seeks to investigate the predictive value of inflammatory indices concerning overall survival (OS) among diabetic cancer patients. METHODS: We analyzed data from the National Health and Nutrition Examination Survey between 1999 and 2020. Using four immune-related markers, we employed the log-rank method, multivariate Cox regression, and subgroup analysis to explore the predictive capacity of these markers for OS among adult individuals with diabetes and cancer. RESULTS: Our study identified four systemic immune-inflammatory indices that demonstrated significant predictive potential for OS among diabetic cancer patients, namely systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio (all p values < 0.05). Notably, these inflammatory biomarkers still maintain their predictive value after adjusting potential confounding factors. The analysis using restrictive cubic splines revealed significant non-linear relationships between inflammatory biomarkers and OS. CONCLUSION: The findings presented in this study underscore the potential of inflammatory markers as prognostic indicators and their crucial role in enhancing risk assessment for diabetic patients with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. wwei9500@smu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Dong, P., & Wang, W. (2024). Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey. Acta Diabetologica, 61(11), 1403-1412. https://doi.org/10.1007/s00592-024-02301-5
Vancouver
Li W, Dong P, Wang W. Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey. Acta Diabetologica. 2024;61(11):1403-1412. doi:10.1007/s00592-024-02301-5
BibTeX
@article{Li2024,
author = {Li, Wenjie and Dong, Peixin and Wang, Wei},
title = {Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey},
journal = {Acta Diabetologica},
year = {2024},
volume = {61},
number = {11},
pages = {1403--1412},
doi = {10.1007/s00592-024-02301-5}
}
EUVIMED